Morgan Stanley Maintains a Hold on Pfizer (PFE)

Pfizer Inc. (NYSE:PFE) is one of the best cheap stocks under $50 to buy now. On July 10, Morgan Stanley analyst Terrence Flynn reiterated a hold rating on Pfizer Inc. (NYSE:PFE), setting a $32 price target.

The company declared a $0.43 fiscal Q3 2025 dividend on June 25 on its common stock, payable September 2 to holders of record at the close of business on July 25. The fiscal Q3 2025 cash dividend marks Pfizer Inc.’s (NYSE:PFE) 347th consecutive quarterly dividend.

Pfizer Inc. (NYSE:PFE) is a global biopharmaceutical company that manufactures, develops, markets, and sells biopharmaceutical products worldwide. It advances wellness, prevention, treatment, and cures in developing and emerging markets.

While we acknowledge the potential of PFE as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.